145 related articles for article (PubMed ID: 11215576)
1. CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Mov Disord; 2001 Jan; 16(1):144-9. PubMed ID: 11215576
[TBL] [Abstract][Full Text] [Related]
2. Circadian changes in CSF dopaminergic measures in restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Sleep Med; 2006 Apr; 7(3):263-8. PubMed ID: 16564215
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
5. Circadian rhythms in RLS.
Högl B
Sleep Med; 2006 Apr; 7(3):209-10. PubMed ID: 16564744
[No Abstract] [Full Text] [Related]
6. High-performance liquid chromatographic measurement of cerebrospinal fluid tetrahydrobiopterin, neopterin, homovanillic acid and 5-hydroxindoleacetic acid in neurological diseases.
Candito M; Nagatsu T; Chambon P; Chatel M
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):61-6. PubMed ID: 7524948
[TBL] [Abstract][Full Text] [Related]
7. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid.
Geracioti TD; Keck PE; Ekhator NN; West SA; Baker DG; Hill KK; Bruce AB; Wortman MD
Biol Psychiatry; 1998 Aug; 44(3):228-33. PubMed ID: 9693394
[TBL] [Abstract][Full Text] [Related]
8. Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.
Kuśmierska K; Szymańska K; Rokicki D; Kotulska K; Jóźwiak S; Sykut-Cegielska J; Mierzewska H; Szczepanik E; Pronicka E; Demkow U
Adv Exp Med Biol; 2016; 878():73-82. PubMed ID: 26453071
[TBL] [Abstract][Full Text] [Related]
9. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
11. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.
Stiasny-Kolster K; Möller JC; Zschocke J; Bandmann O; Cassel W; Oertel WH; Hoffmann GF
Mov Disord; 2004 Feb; 19(2):192-6. PubMed ID: 14978675
[TBL] [Abstract][Full Text] [Related]
12. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations.
Verbeek MM; Blom AM; Wevers RA; Lagerwerf AJ; van de Geer J; Willemsen MA
Mol Genet Metab; 2008 Nov; 95(3):127-32. PubMed ID: 18722797
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.
Rubach MP; Mukemba JP; Florence SM; Lopansri BK; Hyland K; Simmons RA; Langelier C; Nakielny S; DeRisi JL; Yeo TW; Anstey NM; Weinberg JB; Mwaikambo ED; Granger DL
J Infect Dis; 2021 Oct; 224(8):1432-1441. PubMed ID: 33617646
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation.
Fink JK; Ravin P; Argoff CE; Levine RA; Brady RO; Hallett M; Barton NW
Neurology; 1989 Oct; 39(10):1393-5. PubMed ID: 2477772
[TBL] [Abstract][Full Text] [Related]
15. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
16. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study.
Nisijima K; Ishiguro T
Biol Psychiatry; 1993 Jan; 33(1):45-8. PubMed ID: 7678377
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Barkai AI; Kowalik S; Reches A
Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
[TBL] [Abstract][Full Text] [Related]
19. Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.
Polinsky RJ; Brown RT; Burns RS; Harvey-White J; Kopin IJ
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):914-9. PubMed ID: 2462617
[TBL] [Abstract][Full Text] [Related]
20. The dopamine-serotonin relationship in clozapine response.
Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
